BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10679655)

  • 1. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion?
    Cheng L; Cheville JC; Sebo TJ; Eble JN; Bostwick DG
    Cancer; 2000 Feb; 88(4):853-61. PubMed ID: 10679655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraganglioma of the urinary bladder: can biologic potential be predicted?
    Cheng L; Leibovich BC; Cheville JC; Ramnani DM; Sebo TJ; Neumann RM; Nascimento AG; Zincke H; Bostwick DG
    Cancer; 2000 Feb; 88(4):844-52. PubMed ID: 10679654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic nephrogenic metaplasia of ureter: a morphologic and immunohistochemical study of four cases.
    Gokaslan ST; Krueger JE; Albores-Saavedra J
    Mod Pathol; 2002 Jul; 15(7):765-70. PubMed ID: 12118115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma.
    Xiao GQ; Burstein DE; Miller LK; Unger PD
    Arch Pathol Lab Med; 2006 Jun; 130(6):805-10. PubMed ID: 16740031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic adenoma of the urinary tract: A 6-year single center experience.
    Turcan D; Acikalin MF; Yilmaz E; Canaz F; Arik D
    Pathol Res Pract; 2017 Jul; 213(7):831-835. PubMed ID: 28554748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrogenic adenoma of the bladder. Morphological and immunophenotypic study with particular attention to differential diagnosis].
    Isimbaldi G; Di Nuovo F; Sironi M; Catania G; Bonacina R; Privitera O; Spinelli M
    Pathologica; 1999 Jun; 91(3):192-7. PubMed ID: 10536465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, Ki-67, TERT, and long-term follow-up.
    Simon RA; Peng SL; Liu F; Quddus MR; Zhang C; Steinhoff MM; Lawrence WD; Sung CJ
    Mod Pathol; 2011 Sep; 24(9):1254-61. PubMed ID: 21572399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
    Hansel DE; Nadasdy T; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin is a superior marker for detection of micrometastatic biliary tract carcinoma.
    Natarajan S; Xu F; Gilchrist K; Weber SM
    J Surg Res; 2005 May; 125(1):9-15. PubMed ID: 15836844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrogenic metaplasia of the urothelial mucosa. Apropos of 11 cases].
    Billerey C; Khamlu K; Regin JP; Bittard M; Oppermann A
    Sem Hop; 1984 Mar; 60(10):682-8. PubMed ID: 6322315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
    Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
    Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immature squamous metaplasia (focal atypical epithelial hyperplasia) of the pancreatic duct-immunohistochemical distinction from intraductal carcinoma.
    Mochizuki K; Kondo T; Oishi N; Kawasaki T; Nakazawa T; Yamane T; Katoh R
    Histopathology; 2013 Sep; 63(3):343-50. PubMed ID: 23829443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions.
    Lee JS; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1997; 41(6):1719-25. PubMed ID: 9390131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX2: a reliable marker for nephrogenic adenoma.
    Tong GX; Melamed J; Mansukhani M; Memeo L; Hernandez O; Deng FM; Chiriboga L; Waisman J
    Mod Pathol; 2006 Mar; 19(3):356-63. PubMed ID: 16400326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata.
    Cheng L; Leibovich BC; Cheville JC; Ramnani DM; Sebo TJ; Nehra A; Malek RS; Zincke H; Bostwick DG
    Cancer; 2000 Apr; 88(7):1679-86. PubMed ID: 10738227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.
    López JI; Schiavo-Lena M; Corominas-Cishek A; Yagüe A; Bauleth K; Guarch R; Hes O; Tardanico R
    Virchows Arch; 2013 Dec; 463(6):819-25. PubMed ID: 24142157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma.
    Cheng L; Montironi R; Bostwick DG
    Am J Surg Pathol; 1999 Jul; 23(7):764-71. PubMed ID: 10403298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.